Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 10 Prostatic Neoplasms 8 Colonic Neoplasms 7 Neoplasms 5 Colorectal Neoplasms 5 Multiple Myeloma 4 Smoldering Multiple Myeloma 3 Monoclonal Gammopathy of Undetermined Significance 3 Lung Neoplasms 3 Uterine Cervical Neoplasms 2 Uterine Cervical Dysplasia 2 Stomach Neoplasms 2 Rectal Neoplasms 2 Radiodermatitis 2 Pancreatic Neoplasms 2 Pain 2 Esophageal Neoplasms 2 Breast Carcinoma In Situ 2 Adenomatous Polyposis Coli 2 cyclopia sequence 1 Uterine Neoplasms 1 Tuberous Sclerosis 1 Thrombocythemia, Essential 1 Stomatitis 1 Sezary Syndrome 1 Seizures 1 Psychological Well-Being 1 Prostate Cancer Metastatic Castration Resistant 1 Primary Myelofibrosis 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1

Interventions

AZD 6244 9 Lovastatin 5 Deoxycholic Acid 4 trametinib 3 Lasers, Solid-State 3 mirdametinib 2 fludarabine 2 Transcranial Direct Current Stimulation 2 Sirolimus 2 Polidocanol 2 Magnetic Resonance Imaging 2 Lasers 2 Lamotrigine 2 Inhalation 2 Acetylcysteine 2 thymoglobulin 1 talimogene laherparepvec 1 peginterferon alfa-2b 1 gadolinium compound P760 1 fludarabine phosphate 1 diphenylcyclopropenone 1 cabozantinib 1 binimetinib 1 X-Rays 1 Vitamin D 1 Vincristine 1 Vinblastine 1 Temozolomide 1 Surgical Procedures, Operative 1 Sunitinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Neurofibromatosis 1 × Curcumin × Clear all

NCT05363267 2026-06-01

NF-1, Nutraceutical Intervention

Masonic Cancer Center, University of Minnesota

Phase 1 Active not recruiting

Neurofibromatosis 1

Data powered by HemOnc (CC BY 4.0) Colophon ⚡